{{Rsnum
|rsid=678849
|Gene=OPRD1
|Chromosome=1
|position=28818676
|Orientation=plus
|GMAF=0.4536
|Gene_s=OPRD1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.5 | 54.9 | 25.7
| HCB | 9.5 | 51.1 | 39.4
| JPT | 18.6 | 52.2 | 29.2
| YRI | 67.3 | 29.3 | 3.4
| ASW | 50.9 | 43.9 | 5.3
| CHB | 9.5 | 51.1 | 39.4
| CHD | 9.2 | 47.7 | 43.1
| GIH | 7.0 | 45.0 | 48.0
| LWK | 54.5 | 39.1 | 6.4
| MEX | 41.4 | 46.6 | 12.1
| MKK | 46.8 | 43.6 | 9.6
| TSI | 20.6 | 54.9 | 24.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=22795689
|Title=Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations
|OA=1
}}

{{PMID Auto
|PMID=18518925
|Title=Genetic susceptibility to heroin addiction: a candidate gene association study.
|OA=1
}}

{{PMID Auto
|PMID=23427138
|Title=A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: Replication in elderly and young populations
}}

{{PMID Auto
|PMID=23612435
|Title=An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}